Shivaprakash M. Rudramurthy

Multicenter Epidemiologic Study of Coronavirus Disease–Associated Mucormycosis, India

Ritesh Agarwal, Shivaprakash M. Rudramurthy, Manoj Shevkani et al. · Emerging infectious diseases · 2021 · 459 citations · Full text

Incidence, characteristics and outcome of ICU-acquired candidemia in India

Arunaloke Chakrabarti, Prashant Sood, Shivaprakash M. Rudramurthy et al. · Intensive Care Medicine · 2014 · 436 citations

Icu-acquired Candidemia, Clinical Epidemiology, Vaginitis +7

Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor

Jon H. Condra, Daniel Holder, William A. Schleif et al. · Journal of Virology · 1996 · 405 citations · Full text

Immunology, Vivo Viral Resistance, Molecular Biology +17

A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India

Atul Patel, Harsimran Kaur, Immaculata Xess et al. · Clinical Microbiology and Infection · 2019 · 393 citations · Full text

Multicentre Observational Study, Clinical Epidemiology, Clinical Mycology +5

A prospective multicenter study on mucormycosis in India: Epidemiology, diagnosis, and treatment

Hariprasath Prakash, Anup Ghosh, Shivaprakash M. Rudramurthy et al. · Medical Mycology · 2018 · 379 citations